Skip to main content

Table 1 Demographic, Body Composition, and Serum Metabolic Variables

From: Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis

Variable

HIV-/MC- (n = 22)

HIV-/MC+ (n = 9)

HIV+/MC-(n = 15)

HIV+/MC+ (n = 23)

Age (yrs)

25 ± 6

33 ± 5†

41 ± 6*

42 ± 6*

Median viral load (copies/mL)

NA

NA

UD (0-0)

UD (0-34, 000)

CD4+ T-cells (cells/μL)

NA

NA

585 ± 227

471 ± 202

HIV duration (months)

NA

NA

127 ± 80

113 ± 88

cART duration (months)

NA

NA

66 ± 54

72 ± 72

BMI (kg/m2)

24 ± 2

37 ± 2‡

24 ± 4

31 ± 5§

Waist circumference (cm)

82 ± 5

122 ± 9‡

84 ± 6

106 ± 13§

FFM (kg)

64 ± 7

78 ± 8

60 ± 10

70 ± 16

Fat mass (kg)

13 ± 6

37 ± 6‡

11 ± 5

24 ± 10§

Fasting glucose (mg/dL)

90 ± 5

100 ± 8§

86 ± 6

94 ± 8¶

Fasting insulin (μU/mL)

4.7 ± 2.7

20.2 ± 14.0§

4.8 ± 2.2

14.8 ± 6.0§

Fasting HOMA

1.1 ± 0.7

5.1 ± 3.7§

1.1 ± 0.5

3.4 ± 1.4§

TG (mg/dL)

90 ± 24

271 ± 117§

126 ± 69†

186 ± 89†

HDL (mg/dL)

51 ± 9

37 ± 8†

48 ± 13

38 ± 10†

LDL (mg/dL)

91 ± 21.1

108 ± 33§

87 ± 23

108 ± 28§

Chol (mg/dL)

160 ± 26

194 ± 38

159 ± 28

181 ± 36

Lactate (μmol/L)

857 ± 377

887 ± 464

572 ± 147

808 ± 282

FFA (μmol/L)

548 ± 254

690 ± 176

663 ± 178

591 ± 174

  1. Data expressed as mean ± SD. UD = undetectable, cART = combination anti-retroviral therapy, BMI = body mass index, FFM = fat free mass, HOMA = homeostasis model of assessment for insulin resistance, TG = triglyceride, HDL = high density lipoprotein, LDL = low density lipoprotein, Chol = total cholesterol, FFA = free fatty acid, *: p < 0.05 vs. HIV-/MC- and HIV-/MC+, †: p < 0.05 vs. HIV-/MC-, ‡: p < 0.05 vs. remaining groups, §: p < 0.05 vs. HIV-/MC- and HIV+/MC-, ¶: p < 0.05 vs. HIV+/MC-.